<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01701557</url>
  </required_header>
  <id_info>
    <org_study_id>06-0846</org_study_id>
    <nct_id>NCT01701557</nct_id>
  </id_info>
  <brief_title>Fluid Resuscitation for Pediatric Diabetic Ketoacidosis</brief_title>
  <official_title>Fluid Resuscitation for Pediatric Diabetic Ketoacidosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized trial to determine if the volume of fluid administration in pediatric patients
      with DKA impacts the rate of normalization of serum bicarbonate, pH as well as the length of
      treatment
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized trial of two initial volumes of IVF and subsequent administration rates. Group I
      received 10 mL/kg of NS intravenous bolus over the first hour followed by 他 NS with potassium
      replacement at 1.25 times maintenance and Group II received 20 mL/kg of NS intravenous bolus
      over the first hour followed by 他 NS with potassium replacement at 1.5 times maintenance. The
      specific variables measured included demographics (age, gender, and race/ethnicity) and
      routine laboratory values (pH, pCO2, plasma glucose, electrolytes, bicarbonate, sodium,
      chloride, BUN. Length of treatment was defined as a time of the hospital stay after the start
      of IVF infusion.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">June 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>time to normalization of bicarbonate and pH</measure>
    <time_frame>start of treatment until resolution of DKA an expected average of 12 to 24 hours</time_frame>
    <description>Laboratory parameters were measured hourly for the first 4 hours, and every 2 to3 hours thereafter until acid-base normalization (pH was above 7.3 or the HCO3 was above 15 mmol/L)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the length of treatment</measure>
    <time_frame>discharge from the hospital, an expected average of 1-2 days</time_frame>
    <description>Length of treatment was defined as a time of the hospital stay after the start of IVF infusion</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>slow fluid rate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>bolus 10 ml/kg of NS followed by 1.25 times maintenance rate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fast fluid rate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>bolus 20 ml/kg of NS followed by 1.5 times maintenance rate</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>slow fluid rate</intervention_name>
    <description>10 mL/kg of NS intravenous bolus over the first hour followed by 他 NS with potassium replacement at 1.25 times maintenance</description>
    <arm_group_label>slow fluid rate</arm_group_label>
    <other_name>normal saline</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>fast fluid rate</intervention_name>
    <description>20 mL/kg of NS intravenous bolus over the first hour followed by 他 NS with potassium replacement at 1.5 times maintenance</description>
    <arm_group_label>Fast fluid rate</arm_group_label>
    <other_name>normal saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1 day to 18 years of age

          -  type 1 diabetes

          -  presence of DKA, as defined by glucose &gt;250 mg/dl, accumulation of ketone bodies in
             the blood, and metabolic acidosis (venous pH &lt; 7.30 or serum bicarbonate &lt; 15 mmol/L.)

        Exclusion Criteria:

          -  requirement for additional fluid resuscitation for hemodynamic instability

          -  weight greater than 70 kilograms
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arleta Rewers, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>the Childrens Hospital Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 1, 2012</study_first_submitted>
  <study_first_submitted_qc>October 3, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 5, 2012</study_first_posted>
  <last_update_submitted>October 3, 2012</last_update_submitted>
  <last_update_submitted_qc>October 3, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 5, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ketoacidosis Fluids</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketosis</mesh_term>
    <mesh_term>Diabetic Ketoacidosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

